Keywords: USA. Justice Dept, False claims, Pricing, Medicard, Abbott, Roxane, Beorhringer Ingelheim, Braun, Kos Pharma

Three drugmakers - Abbott, Roxane and Braun - to pay $421 million to settle false claims cases, says US Justice Dept

Article | 08 December 2010

Print This

US health care major Abbott Laboratories (NYSE: ABT), B Braun Medical (a US subsidiary of Germany’s B Braun ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in